Dr. Zisman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Gossamer Bio
Suite 200
San Diego, CA 92121Phone+1 518-573-8315- Is this information wrong?
Education & Training
- Westchester Medical CenterResidency, Internal Medicine, 1987 - 1990
- Albert Einstein College of MedicineClass of 1987
Certifications & Licensure
- CA State Medical License 2019 - 2025
- NY State Medical License 1988 - 2018
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 15 citationsInhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension.Anna Galkin, Ravikumar Sitapara, Bryan Clemons, Eduardo Garcia, Michael Kennedy, David Guimond, Laura L Carter, Ashley Douthitt, Robin Osterhout, Aneta Gandjeva, Debor...> ;The European Respiratory Journal. 2022 Dec 1
- 20 citationsTORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension.Robert P. Frantz, Raymond L. Benza, Richard N. Channick, Kelly Chin, Luke Howard, Vallerie V. McLaughlin, Olivier Sitbon, Roham T. Zamanian, Anna R. Hemnes, Matt Crave...> ;Pulmonary Circulation. 2021 Oct 22
- 1 citationsEXPRESS: Phosphoproteomic Analysis of Lung tissue from Patients with Pulmonary Arterial Hypertension:Ravikumar Sitapara, TuKiet T. Lam, Aneta Gandjeva, Rubin M. Tuder, Lawrence S. Zisman> ;Pulmonary Circulation. 2021 Jul 9
- Join now to see all
Grant Support
- Phosphopeptide Mapping Of Plexiform Lesions In Pulmonary Arterial HypertensionNational Heart, Lung, And Blood Institute2011
- A Pdgfr Inhibitor For The Treatment Of Pulmonary Arterial HypertensionNational Heart, Lung, And Blood Institute2010
- A Novel JAK Inhibitor For The Treatment Of Pulmonary Arterial HypertensionNational Heart, Lung, And Blood Institute2010
- Effect Of Cardiac Tissue Specific Angiotensin Converting Enzyme InhibitionNational Center For Research Resources1998–2000
- Cardiac Renin/Angiotensin System In Heart FailureNational Heart, Lung, And Blood Institute1999
- Cardiac Renin/Angiotensin System In Heart FailureNational Heart, Lung, And Blood Institute1998
- Cardiac Renin/Angiotensin System In Heart FailureNational Heart, Lung, And Blood Institute1995–1998
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: